Brind.

William Blair maintained a bullish Buy stance on Ultragenyx Pharmaceutical on July 16, 2025.

1 report, 1 independent Updated Jul 16

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Ultragenyx Pharmaceutical William P. Blair

Keep exploring

The entities involved

Ultragenyx Pharmaceutical
biopharmaceutical company based in Novato, California, United States

Nothing else this week.
William P. Blair
American astrophysicist
- Watsco reported margin impacts due to subdued international sales in Mexico, with analysts questioning volume trends.Sun 06:23

Coverage

Newest first; wire copies grouped

Jul 16Insider MonkeyWilliam Blair Maintains a Buy on Ultragenyx Pharmaceutical (RARE) Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the best oversold NASDAQ stocks to buy now. On July 14, William Blair analyst